Jin Yan, Randall James W, Elhalawani Hesham, Feghali Karine A Al, Elliott Andrew M, Anderson Brian M, Lacerda Lara, Tran Benjamin L, Mohamed Abdallah S, Brock Kristy K, Fuller Clifton D, Chung Caroline
Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The University of Texas Medical Branch, Galveston, TX 77555, USA.
Cancers (Basel). 2020 Feb 29;12(3):568. doi: 10.3390/cancers12030568.
Glioblastoma is an aggressive brain tumor with a propensity for intracranial recurrence. We hypothesized that tumors can be visualized with diffusion tensor imaging (DTI) before they are detected on anatomical magnetic resonance (MR) images. We retrospectively analyzed serial MR images from 30 patients, including the DTI and T1-weighted images at recurrence, at 2 months and 4 months before recurrence, and at 1 month after radiation therapy. The diffusion maps and T1 images were deformably registered longitudinally. The recurrent tumor was manually segmented on the T1-weighted image and then applied to the diffusion maps at each time point to collect mean FA, diffusivities, and neurite density index (NDI) values, respectively. Group analysis of variance showed significant changes in FA ( = 0.01) and NDI ( = 0.0015) over time. Pairwise t tests also revealed that FA and NDI at 2 months before recurrence were 11.2% and 6.4% lower than those at 1 month after radiation therapy ( < 0.05), respectively. Changes in FA and NDI were observed 2 months before recurrence, suggesting that progressive microstructural changes and neurite density loss may be detectable before tumor detection in anatomical MR images. FA and NDI may serve as non-contrast MR-based biomarkers for detecting subclinical tumors.
胶质母细胞瘤是一种侵袭性脑肿瘤,易于颅内复发。我们假设在解剖磁共振(MR)图像检测到肿瘤之前,通过扩散张量成像(DTI)可以将肿瘤可视化。我们回顾性分析了30例患者的系列MR图像,包括复发时、复发前2个月和4个月以及放射治疗后1个月的DTI和T1加权图像。扩散图和T1图像进行了纵向可变形配准。在T1加权图像上手动分割复发肿瘤,然后应用于每个时间点的扩散图,分别收集平均FA、扩散率和神经突密度指数(NDI)值。方差组分析显示FA( = 0.01)和NDI( = 0.0015)随时间有显著变化。成对t检验还显示,复发前2个月的FA和NDI分别比放射治疗后1个月低11.2%和6.4%( < 0.05)。在复发前2个月观察到FA和NDI的变化,这表明在解剖MR图像检测到肿瘤之前,可能检测到渐进性微观结构变化和神经突密度损失。FA和NDI可作为基于非对比MR的生物标志物用于检测亚临床肿瘤。